Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Economic evaluation of intravenous iodinated contrast media in Italy.

Iannazzo S, Vandekerckhove S, De Francesco M, Nayak A, Ronco C, Morana G, Valentino M.

Int J Technol Assess Health Care. 2014 Jan;30(1):69-77. doi: 10.1017/S0266462313000706. Epub 2014 Jan 31. Erratum in: Int J Technol Assess Health Care. 2014 Jul;30(3):341.

PMID:
24485022
2.

The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.

Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS.

JACC Cardiovasc Interv. 2009 Jul;2(7):645-54. doi: 10.1016/j.jcin.2009.05.002. Review. Erratum in: JACC Cardiovasc Interv. 2009 Nov;2(11):1167.

3.

Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain.

De Francesco M, Ronco C, Wacinski PJ, Wessely R, Hernández F, Lamotte M.

J Med Econ. 2016;19(2):158-68. doi: 10.3111/13696998.2015.1105809. Epub 2015 Nov 11. Review.

PMID:
26451530
4.

Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.

Karlsberg RP, Dohad SY, Sheng R; Iodixanol Peripheral Computed Tomographic Angiography Study Investigator Panel.

J Vasc Interv Radiol. 2011 Aug;22(8):1159-65. doi: 10.1016/j.jvir.2011.03.020. Epub 2011 May 14.

PMID:
21570871
5.

Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy.

Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Lundkvist J.

Am Heart J. 2005 Feb;149(2):298-303.

PMID:
15846268
6.

Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration of iodinated contrast media.

Karlsberg RP, Dohad SY, Sheng R; Iodixanol Peripheral CTA Study Investigator Panel.

J Nephrol. 2010 Nov-Dec;23(6):658-66.

PMID:
20540038
7.

The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Reed MC, Moscucci M, Smith DE, Share D, LaLonde T, Mahmood SA, D'Haem C, McNamara R, Greenbaum A, Gurm HS.

J Invasive Cardiol. 2010 Oct;22(10):467-72.

8.

Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.

Chicaíza-Becerra LA, García-Molina M, Gamboa Ó.

Biomedica. 2012 Jun;32(2):182-8. doi: 10.1590/S0120-41572012000300005. Review.

10.

Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.

Heinrich MC, Häberle L, Müller V, Bautz W, Uder M.

Radiology. 2009 Jan;250(1):68-86. doi: 10.1148/radiol.2501080833.

PMID:
19092091
11.

A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.

Zhang BC, Wu Q, Wang C, Li DY, Wang ZR.

J Cardiol. 2014 Apr;63(4):260-8. doi: 10.1016/j.jjcc.2013.11.021. Epub 2014 Jan 4. Review.

12.

Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.

Alexopoulos E, Spargias K, Kyrzopoulos S, Manginas A, Pavlides G, Voudris V, Lerakis S, McLean DS, Cokkinos DV.

Am J Med Sci. 2010 Jan;339(1):25-30. doi: 10.1097/MAJ.0b013e3181c06e70.

PMID:
19996728
14.

A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.

McCullough PA, Bertrand ME, Brinker JA, Stacul F.

J Am Coll Cardiol. 2006 Aug 15;48(4):692-9. Epub 2006 Jul 24.

15.

Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.

Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH.

Radiology. 2013 Apr;267(1):94-105. doi: 10.1148/radiol.12121394. Epub 2013 Jan 29.

16.

Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.

Ladwig M, Flemming B, Seeliger E, Sargsyan L, Persson PB.

Invest Radiol. 2011 Nov;46(11):672-7. doi: 10.1097/RLI.0b013e31822311a9.

PMID:
21623210
17.

Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.

Eng J, Wilson RF, Subramaniam RM, Zhang A, Suarez-Cuervo C, Turban S, Choi MJ, Sherrod C, Hutfless S, Iyoha EE, Bass EB.

Ann Intern Med. 2016 Mar 15;164(6):417-24. doi: 10.7326/M15-1402. Epub 2016 Feb 2. Review.

PMID:
26830055
18.

[Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].

Schönefeld E, Höwler S, Osada N, Torsello G.

Zentralbl Chir. 2011 Oct;136(5):426-30. doi: 10.1055/s-0031-1283759. Epub 2011 Oct 18. German.

PMID:
22009540
19.
20.

Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.

From AM, Al Badarin FJ, McDonald FS, Bartholmai BJ, Cha SS, Rihal CS.

Circ Cardiovasc Interv. 2010 Aug;3(4):351-8. doi: 10.1161/CIRCINTERVENTIONS.109.917070. Epub 2010 Jul 20.

Supplemental Content

Support Center